StonvexLoading…
StonvexCore line items from NN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $993.95K | $995.00K | $4.57M | $3.63M | $2.74M |
Operating Income | Not available | $-19.34M | $-70.23M | $-54.11M | $-34.24M |
Net Income | Not available | $-10.62M | $-189.25M | $-121.29M | $-63.20M |
EPS (Diluted) | $-0.15 | $-0.12 | $-1.42 | $-0.93 | $-0.93 |
Total Assets | Not available | $235.64M | $247.02M | $263.07M | $256.74M |
Total Liabilities | Not available | $325.61M | $333.25M | $285.19M | $303.96M |
Cash & Equivalents | Not available | $30.60M | $44.76M | $89.99M | $58.87M |
Free Cash Flow OCF − CapEx | Not available | $-10.05M | $-50.80M | $-34.73M | $-25.76M |
Shares Outstanding | Not available | 136.06M | 135.37M | 134.73M | 133.01M |